Erbitux slightly boosts survival in cancer study (AP)AP - Adding the novel cancer drug Erbitux to standard chemotherapy helped advanced lung cancer patients live just a month longer than chemo alone, a study found.
http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/ap/med_lung_cancer_targeted_drug.html